Vivani’s GLP-1 implant tests a new path for weight-loss maintenance
Novo Nordisk and Vivani will evaluate a semaglutide implant aimed at keeping patients on obesity treatment longer.
Startups & Deals Reporter
Jordan tracks the companies going public, the funding rounds, and the fintech products changing how a generation moves money.
Novo Nordisk and Vivani will evaluate a semaglutide implant aimed at keeping patients on obesity treatment longer.
Consumer prices rose 4.38% in June, above a Reuters poll estimate, as fuel risks and uneven monsoon rains added to India’s inflati...
Burberry shares rose after Miss Tweed reported growing speculation that Moncler may consider a takeover approach.
TipRanks highlighted bullish calls on Amazon, Marvell and AMD as investors weigh AI spending, chip demand and geopolitical risk.
A failed Wainua trial had a limited model impact, analysts said, but the stock drop showed investors are watching AstraZeneca’s br...
The German startup said the round values it at $18 billion, putting more private capital behind AI-enabled defense systems in Euro...
DirecTV will assume about $9.75 billion of Dish DBS net debt as EchoStar cuts debt and refinancing pressure.
Apple’s trade-secret lawsuit against OpenAI set off fresh public attacks between Elon Musk and Sam Altman as their AI rivalry heat...